Monoclonal Gammopathy–Associated Peripheral Neuropathy: Diagnosis and Management - Mayo Clinic Proceedings
Prevalence of monoclonal gammopathies and clinical outcomes in a high-risk US population screened by mass spectrometry: a multicentre cohort study - The Lancet Haematology
Prognosis of young patients with monoclonal gammopathy of undetermined significance (MGUS) | Blood Cancer Journal
Cutaneous manifestations of monoclonal gammopathy | Blood Cancer Journal
Management of Monoclonal Gammopathy of Uncertain Significance | SpringerLink
Excluding myeloma diagnosis using revised thresholds for serum free light chain ratios and M-protein levels | Haematologica
What is the significance of monoclonal gammopathy of undetermined significance? | RCP Journals
IJMS | Free Full-Text | Prevention Is the Best Treatment: The Case for Understanding the Transition from Monoclonal Gammopathy of Undetermined Significance to Myeloma | HTML
Monoclonal Gammopathy of Undetermined Significance (MGUS)
Monoclonal gammopathy of undetermined significance - Wikipedia
IgM-MGUS and associated membranoproliferative glomerulonephritis during IVIG administration | SpringerLink
Monoclonal gammopathy of undetermined significance - Kyle - 2006 - British Journal of Haematology - Wiley Online Library
A Long-Term Study of Prognosis in Monoclonal Gammopathy of Undetermined Significance | NEJM
Neuropathy associated with IgA monoclonal Gammopathy. A harbinger of AL amyloidosis - Journal of the Neurological Sciences
Contributions of the Bone Microenvironment to Monoclonal Gammopathy of Undetermined Significance Pathogenesis | SpringerLink
MGUS Predicts Worse Prognosis in Patients with Coronary Artery Disease | SpringerLink
Absolute Risk of Progression of MGUS to Myeloma or Related Disorders... | Download Table
Detection and prevalence of monoclonal gammopathy of undetermined significance: a study utilizing mass spectrometry-based monoclonal immunoglobulin rapid accurate mass measurement | Blood Cancer Journal
Monoclonal gammopathy of renal significance: Early diagnosis is key - ScienceDirect
Monoclonal gammopathy of undetermined significance: A primary care guide | Cleveland Clinic Journal of Medicine
The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European Myeloma Network | Haematologica
Rheumatologic diseases impact the risk of progression of MGUS to overt multiple myeloma - ScienceDirect
Monoclonal gammopathy of renal significance: Early diagnosis is key | Nefrología
Comparison of MGUS and multiple myeloma variants | Download Table
Secondary MGUS after autologous hematopoietic progenitor cell transplantation in plasma cell myeloma: a matter of undetermined significance | Bone Marrow Transplantation
Risk Stratifying Patients with Monoclonal Gammopathy of Undetermined Significance – Consult QD
